Mild

Xanthomas of Tendons - Causes, Treatment & When to See a Doctor

📅 Updated: May 2026 ⏱ 6 min read ✅ Medically reviewed

Contents

```html Xanthomas of Tendons – Causes, Symptoms, Diagnosis & Treatment

Xanthomas of Tendons: A Comprehensive Guide

What is Xanthomas of Tendons?

Xanthomas are deposits of cholesterol‑rich material that appear as yellowish, papular or nodular lesions on the skin or in connective tissue. When these deposits form within or on top of tendons—most often the Achilles tendons, extensor tendons of the hands, and the tendons of the feet—they are called tendon xanthomas (also known as tendinous xanthomas). The lesions feel firm, may be slightly raised, and can range from a few millimetres to several centimetres in diameter.

Because tendon xanthomas are almost always linked to an underlying disorder of lipid metabolism, their presence is an important clinical clue that a person may have a lifelong risk of atherosclerotic cardiovascular disease.

Common Causes

Most tendon xanthomas develop secondary to chronic elevations in low‑density lipoprotein (LDL) cholesterol. The most frequent underlying conditions are:

  • Familial hypercholesterolemia (FH) – an autosomal‑dominant genetic disorder causing markedly high LDL from birth.
  • Familial combined hyperlipidemia – elevated LDL and triglycerides, often with a family history of premature heart disease.
  • Familial defective apolipoprotein B‑100 – a rare mutation that impairs LDL receptor binding.
  • Polygenic hypercholesterolemia – a multifactorial rise in LDL due to the combined effect of several genes and lifestyle.
  • Secondary hyperlipidemia caused by:
    • Uncontrolled diabetes mellitus
    • Hypothyroidism
    • Nephrotic syndrome
    • Chronic kidney disease on dialysis
  • Cholesterol‑laden macrophage infiltration in tendons after long‑term use of certain medications (e.g., corticosteroids, some antiretrovirals).
  • Rare lipid storage diseases such as sitosterolemia or cerebrotendinous xanthomatosis.
  • Secondary to dietary factors – very high intake of saturated fats and trans‑fatty acids over many years can exacerbate an underlying genetic predisposition.

Associated Symptoms

While tendon xanthomas themselves are generally painless, they often coexist with other clinical findings:

  • Other cutaneous xanthomas (plane, eruptive, or tuberous) on elbows, knees, or buttocks.
  • Premature coronary artery disease – angina, myocardial infarction before age 55 in men or 65 in women.
  • Peripheral arterial disease – claudication, cold feet, or non‑healing ulcers.
  • Arcus corneae – a gray‑white ring around the cornea, more common in hypercholesterolemic patients.
  • Family history of early‑onset heart attacks or strokes.
  • In rare lipid‑storage disorders: neurological symptoms (ataxia, seizures) or cataracts.

When to See a Doctor

Because tendon xanthomas signal a systemic lipid problem, timely medical evaluation is essential. Seek care if you notice any of the following:

  • Yellowish, firm nodules appearing on the Achilles tendon, hands, or feet.
  • A family history of high cholesterol, early heart attacks, or known FH.
  • Chest pain, shortness of breath, or unexplained fatigue—possible signs of heart disease.
  • Sudden increase in size or pain in an existing nodule.
  • Skin changes elsewhere (e.g., eruptive xanthomas on the buttocks or abdomen).

Diagnosis

Diagnosing tendon xanthomas involves a combination of clinical examination, laboratory testing, and imaging.

1. Physical Examination

The clinician gently palpates the tendons. Tendon xanthomas feel firm, non‑compressible, and are typically immobile relative to the surrounding tissue. Their yellow hue may be subtle, especially in patients with darker skin tones.

2. Laboratory Tests

  • Lipid panel – total cholesterol, LDL‑C, HDL‑C, triglycerides.
  • Genetic testing for LDLR, APOB, or PCSK9 mutations when FH is suspected.
  • Thyroid‑stimulating hormone (TSH) and free T4 to rule out hypothyroidism.
  • Fasting glucose or HbA1c if diabetes is a concern.

3. Imaging

  • Ultrasound – reveals hyperechoic, heterogeneous thickening within the tendon.
  • MRI – provides detailed soft‑tissue contrast; useful when surgical planning is needed.
  • CT scan – can quantify calcium‑containing xanthomas, though less commonly used.

4. Histopathology (Rare)

If the diagnosis is uncertain, a biopsy may be performed. Microscopy shows lipid‑laden macrophages (foam cells) within the tendon matrix, confirming a xanthoma.

Treatment Options

Treatment focuses on two goals: reducing the underlying lipid abnormality and managing the local lesion.

1. Lipid‑Lowering Therapy

  • Statins (e.g., atorvastatin, rosuvastatin) – first‑line agents that lower LDL‑C by 30‑50 %.
  • Ezetimibe** – blocks intestinal cholesterol absorption; often added to statin therapy.
  • PCSK9 inhibitors (evolocumab, alirocumab) – monoclonal antibodies that can reduce LDL‑C an additional 60 % in refractory FH.
  • Bile‑acid sequestrants (cholestyramine) – modest LDL reduction, useful when statins are not tolerated.
  • Lipid‑apheresis – extracorporeal removal of LDL for severe homozygous FH or when drug therapy fails.

Achieving LDL‑C targets (often < 70 mg/dL for high‑risk patients) can halt progression and may even lead to partial regression of tendon xanthomas over years.

2. Lifestyle Modifications

  • Diet – a heart‑healthy Mediterranean or DASH diet low in saturated fat, trans‑fat, and cholesterol.
  • Physical activity – at least 150 minutes of moderate aerobic exercise per week, which raises HDL‑C and improves endothelial health.
  • Weight management – obesity compounds lipid abnormalities.
  • Smoking cessation – smoking accelerates atherosclerosis and worsens FH outcomes.

3. Local Management

  • Observation – many asymptomatic tendon xanthomas are simply monitored.
  • Surgical excision – considered for painful, function‑limiting, or cosmetically concerning nodules. Recurrence can occur if lipid levels remain uncontrolled.
  • Laser therapy or cryotherapy – limited evidence; usually reserved for small, superficial lesions.

4. Managing Cardiovascular Risk

Because tendon xanthomas are a marker for premature atherosclerosis, patients should also receive:

  • Blood pressure control (goal < 130/80 mmHg).
  • Aspirin prophylaxis when indicated.
  • Diabetes optimization (HbA1c < 7 %).
  • Regular cardiovascular screening (e.g., coronary calcium scoring, stress testing).

Prevention Tips

While genetic forms of hypercholesterolemia cannot be prevented, the risk of developing tendon xanthomas—or their progression—can be minimized through the following strategies:

  • Know your family history; request lipid screening for all first‑degree relatives if FH is suspected.
  • Undergo a fasting lipid panel at least once every 5 years after age 20, or earlier if risk factors exist.
  • Adopt a diet rich in fruits, vegetables, whole grains, oily fish, and nuts; limit red meat and processed foods.
  • Maintain an active lifestyle—aim for 30 minutes of brisk walking most days.
  • Never smoke; use nicotine‑replacement therapy if needed.
  • If prescribed lipid‑lowering medication, take it exactly as directed and attend follow‑up labs.
  • Control comorbidities such as hypothyroidism, diabetes, and renal disease promptly.
  • Educate children and adolescents about healthy eating; early intervention reduces lifelong cardiovascular burden.

Emergency Warning Signs

Immediate medical attention is required if you experience any of the following:
  • Sudden, severe chest pain radiating to the arm, jaw, or back (possible heart attack).
  • Shortness of breath, fainting, or rapid, irregular heartbeat.
  • Sudden weakness, numbness, or difficulty speaking (possible stroke).
  • Rapid swelling, redness, or severe pain in a limb that could signal a deep‑vein thrombosis.
  • Rapid enlargement of a tendon xanthoma accompanied by warmth or pus – could indicate infection.
Call emergency services (e.g., 911 in the U.S.) or go to the nearest emergency department without delay.

Key Take‑aways

Tendon xanthomas are more than a cosmetic concern; they are a visual sign of an underlying lipid disorder that dramatically raises the risk of heart attack, stroke, and peripheral vascular disease. Early recognition, aggressive lipid‑lowering therapy, and lifestyle changes can halt progression, improve cardiovascular outcomes, and, over time, may reduce the size of the nodules.

For personalized advice, consult a primary‑care physician, cardiologist, or lipid specialist. Regular monitoring and adherence to treatment plans are the cornerstones of managing this condition safely.

References

  • Mayo Clinic. “Familial hypercholesterolemia.” https://www.mayoclinic.org/diseases-conditions/familial-hypercholesterolemia
  • National Heart, Lung, and Blood Institute. “High Blood Cholesterol.” https://www.nhlbi.nih.gov/health/high-blood-cholesterol
  • American Heart Association. “Understanding Cholesterol and Lipids.” https://www.heart.org/en/health-topics/cholesterol
  • Cleveland Clinic. “Xanthomas: Causes, Symptoms, Treatment.” https://my.clevelandclinic.org/health/diseases/14763-xanthomas
  • World Health Organization. “Guidelines on Pharmacological Treatment of Lipid Disorders.” 2023.
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References